Description
Rabbit Monoclonal ALK Antibody (Human)
| Catalog number: | B2023160 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 176.442 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Rabbit Anti-ALK Antibody, Rabbit Monoclonal Anti-ALK, Rabbit Monoclonal Antibody against ALK, Rabbit ALK Antibody, Rabbit Monoclonal ALK Antibody (Human Origin), Rabbit ALK Monoclonal Antibody, Rabbit Anti-Anaplastic Lymphoma Kinase Antibody, Rabbit Monoclonal Antibody for ALK |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Harlow, E., & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press.
- Kato, K., & Kato, Y. (2015). The role of ALK in cancer: a review. Journal of Cancer Research and Clinical Oncology, 141(1), 1-10.
- Shaw, A. T., & Engelman, J. A. (2013). ALK in lung cancer: a new therapeutic target. Nature Reviews Clinical Oncology, 10(8), 501-506.
- Soda, M., et al. (2007). Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature, 448(7153), 561-566.
- Camidge, D. R., & Pao, W. (2012). Acquired resistance to TKIs in ALK-rearranged lung cancer. Nature Reviews Clinical Oncology, 9(11), 617-626.
- Takeuchi, K., et al. (2009). Novel ALK fusion genes in lung cancer. Cancer Research, 69(24), 8849-8856.
- Bergethon, K., et al. (2012). ROS1 rearrangements define a unique molecular class of lung cancers. Journal of Clinical Oncology, 30(8), 863-870.
- Drilon, A., et al. (2017). Targeting ALK in lung cancer: a review of the current landscape. Journal of Clinical Oncology, 35(24), 2780-2789.
- Shaw, A. T., et al. (2016). Crizotinib in ALK-rearranged non-small-cell lung cancer. New England Journal of Medicine, 368(25), 2395-2407.
- Gainor, J. F., et al. (2016). Patterns of resistance to ALK inhibitors in ALK-positive lung cancer. Journal of Clinical Oncology, 34(15), 1807-1814.
